טוען...
Short-Term Fenofibrate Treatment Reduces Elevated Plasma Lp-PLA(2) Mass and sVCAM-1 Levels in a Sub-Cohort of Hypertriglyceridemic GOLDN Participants
BACKGROUND: High levels of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) are associated with inflammation, atherosclerosis, and CHD events. In addition, Lp-PLA(2) has been linked to classical markers of endothelial activation, including soluble vascular cell adhesion molecule-1 (sVCAM-1). Th...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3138503/ https://ncbi.nlm.nih.gov/pubmed/21757154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2011.01.014 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|